Cargando…
Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade
Autores principales: | Miller, David M., Faulkner-Jones, Beverly E., Stone, James R., Drews, Reed E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594230/ https://www.ncbi.nlm.nih.gov/pubmed/28932782 http://dx.doi.org/10.1016/j.jdcr.2017.06.005 |
Ejemplares similares
-
Immune Checkpoints Expression in Chronic Lung Allograft Rejection
por: Righi, Ilaria, et al.
Publicado: (2021) -
Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients
por: Trager, Megan H, et al.
Publicado: (2020) -
The Current Landscape of Immune Checkpoint Blockade in Metastatic Lung Squamous Cell Carcinoma
por: Yuan, Hong, et al.
Publicado: (2021) -
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
por: Siegel, Jacob D., et al.
Publicado: (2021) -
The genetic determinants of renal allograft rejection
por: Hernandez‐Fuentes, Maria, et al.
Publicado: (2018)